Please login to the form below

Not currently logged in
Email:
Password:

Committee for Medicinal Products for Human Use

This page shows the latest Committee for Medicinal Products for Human Use news and features for those working in and with pharma, biotech and healthcare.

Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US

Lilly asks to revoke emergency authorisation for bamlanivimab monotherapy in the US

Decision promoted by the ‘evolving variant landscape’ in the US. Eli Lilly has asked the US Food and Drug Administration (FDA) to revoke the emergency use authorisation (EUA) for its ... In March, the European Medicines Agency’s (EMA) Committee for

Latest news

More from news
Approximately 0 fully matching, plus 360 partially matching documents found.

Latest Intelligence

  • The evolution of real-world studies The evolution of real-world studies

    Most members of the EMA’s Committee for Medicinal Products for Human Use supported approval on the strength of the analysis but there was some pushback. ... Recognising that, the United Kingdom has sought to position its relatively standardised, single

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    Early signs are looking good: Novartis’ Kymriah (tisagenlecleucel) and Gilead/Kite’s Yescarta (axicabtagene ciloleucel) secured positive opinions from EMA's Committee for Medicinal Products for Human Use (CHMP) in June ... So far, 37 sessions of

  • Drug safety

  • Drug R&D

  • The pill branding The pill branding

    After long discussions between politicians in the respective countries about its safety, and after the CHMP's (EMA Committee for Medicinal Products for Human Use) recommendation, the European Commission finally made ... A promotional claim is not allowed

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

  • CHMP names France's Pierre Demolis vice-chair CHMP names France's Pierre Demolis vice-chair

    The European Medicines Agency (EMA) has appointed France's Dr Pierre Demolis as vice-chair of the Committee for Medicinal Products for Human Use (CHMP). ... In his new role, he will work with chair Dr Tomas Salmonson of Sweden to head the CHMP, which

  • EMA’s Paediatric Committee elects new leaders EMA’s Paediatric Committee elects new leaders

    On their election, Mentzer and van den Berg thanked outgoing chair Daniel Brasseur, who has left the PDCO to become a member of the European Medicines Agency's Committee for Medicinal ... Products for Human Use (CHMP).

  • EMA’s Pharmacovigilance Risk Assessment Committee gains new members EMA’s Pharmacovigilance Risk Assessment Committee gains new members

    Its objective is to assess and monitor safety issues for human medicines, giving recommendations for consideration by the Committee for Medicinal Products for Human Use (CHMP). ... Its current chair is Dr June Raine of the UK's Medicines and Healthcare

  • Dr Ian Hudson elected vice chair of CHMP Dr Ian Hudson elected vice chair of CHMP

    Will serve a three-year term on EMA's scientific advisory committee. The EMA's Committee for Medicinal Products for Human Use (CHMP) has elected Dr Ian Hudson to serve as ... Dr Hudson has been a member of the scientific advisory committee since 2004 and

  • Sweden’s Tomas Salmonson to chair EMA’s CHMP Sweden’s Tomas Salmonson to chair EMA’s CHMP

    He replaces Eric Abadie who retired in April. Tomas Salmonson has been appointed chair of the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). ... EMA's Committee for Proprietary Medicinal Products (CPMP) from 1999

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics